Microcystin-LR exposure disrupts the insulin signaling pathway in C2C12 mice muscle cell line

Microcystin-LR (MC-LR) is a widely produced monocyclic heptapeptides in eutrophication waterbodies. MC-LR can induce various toxic effects in different cells. Our previous studies have found that MC-LR exposure can disrupt insulin signaling pathway in human liver cells (HL 7702). Skeletal muscle is one of the major organs for glucose disposal and responsive to insulin. However, the effects of MC-LR on insulin signaling pathway in muscle cells have not been fully explored. By using C2C12 mice muscle cells, this study aims to investigate the toxic effects of MC-LR in muscle cells with a focus on its effects on insulin signaling pathways. It was found that MC-LR entered into cells and inhibited protein phosphatase 2A (PP2A) significantly. Furthermore, MC-LR increased phosphorylation of Ser302, Ser307, Ser612 of insulin receptor substrate 1, AKT-Ser473, GSK3α-Ser21, and S6K1-Thr389 by inhibiting the activity of PP2A. The results in this study demonstrate that exposure of MCLR can disrupt the insulin pathway in muscle cells.